VIGL
Price
$7.95
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
371.04M
43 days until earnings call
VYGR
Price
$2.96
Change
-$0.01 (-0.34%)
Updated
Jun 27 closing price
Capitalization
163.8M
31 days until earnings call
Interact to see
Advertisement

VIGL vs VYGR

Header iconVIGL vs VYGR Comparison
Open Charts VIGL vs VYGRBanner chart's image
Vigil Neuroscience
Price$7.95
Change-$0.00 (-0.00%)
Volume$303.98K
Capitalization371.04M
Voyager Therapeutics
Price$2.96
Change-$0.01 (-0.34%)
Volume$1.09M
Capitalization163.8M
VIGL vs VYGR Comparison Chart in %
Loading...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VIGL vs. VYGR commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VIGL is a Buy and VYGR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (VIGL: $7.95 vs. VYGR: $2.96)
Brand notoriety: VIGL and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VIGL: 22% vs. VYGR: 189%
Market capitalization -- VIGL: $371.04M vs. VYGR: $163.8M
VIGL [@Biotechnology] is valued at $371.04M. VYGR’s [@Biotechnology] market capitalization is $163.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VIGL’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • VIGL’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than VIGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VIGL’s TA Score shows that 3 TA indicator(s) are bullish while VYGR’s TA Score has 3 bullish TA indicator(s).

  • VIGL’s TA Score: 3 bullish, 4 bearish.
  • VYGR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, VIGL is a better buy in the short-term than VYGR.

Price Growth

VIGL (@Biotechnology) experienced а +0.38% price change this week, while VYGR (@Biotechnology) price change was -2.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

VIGL is expected to report earnings on Aug 12, 2025.

VYGR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIGL($371M) has a higher market cap than VYGR($164M). VIGL YTD gains are higher at: 367.647 vs. VYGR (-47.795). VIGL has higher annual earnings (EBITDA): -91.27M vs. VYGR (-97.25M). VYGR has more cash in the bank: 236M vs. VIGL (87.1M). VIGL has less debt than VYGR: VIGL (12.7M) vs VYGR (42M). VYGR has higher revenues than VIGL: VYGR (67M) vs VIGL (0).
VIGLVYGRVIGL / VYGR
Capitalization371M164M226%
EBITDA-91.27M-97.25M94%
Gain YTD367.647-47.795-769%
P/E RatioN/A6.32-
Revenue067M-
Total Cash87.1M236M37%
Total Debt12.7M42M30%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VIGLVYGR
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGDDF38.550.75
+1.98%
CIE GENERALE DES ETABLISSEMENTS MICHELIN SA CLERMONT-FERRAND
FRSB15.01N/A
N/A
FIRST RESOURCE BANCORP INC.
MTWTF12.31N/A
N/A
Metawater Co Ltd
OTGLF76.00N/A
N/A
CD Projekt SA
XPRCF0.01N/A
N/A
XPLORE RES CORP.

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with MRUS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then MRUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
N/A
MRUS - VIGL
49%
Loosely correlated
-0.47%
IMNN - VIGL
46%
Loosely correlated
-7.34%
ELVN - VIGL
35%
Loosely correlated
-3.95%
VYGR - VIGL
32%
Poorly correlated
-0.34%
VTGN - VIGL
31%
Poorly correlated
-3.90%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-0.34%
RGNX - VYGR
52%
Loosely correlated
-4.11%
TRDA - VYGR
52%
Loosely correlated
-1.57%
KYMR - VYGR
50%
Loosely correlated
-3.48%
XNCR - VYGR
48%
Loosely correlated
-3.10%
IMNM - VYGR
48%
Loosely correlated
-0.23%
More